期刊文献+

实时荧光定量PCR微卫星分析技术检测少突胶质细胞肿瘤染色体1p、19q和10q杂合性缺失

Loss of Heterozygosity in Oligodendroglioma by Real-time Quantitative Polymerase Chain Reaction-based Microsatellite Analysis
下载PDF
导出
摘要 目的建立检测脑胶质瘤染色体1p、19q和10q杂合性缺失(LOH)的实验室新方法。方法采用Taqman探针法对38例少突胶质细胞肿瘤标本进行染色体1p、19q和10q LOH检测。结果 38例少突胶质细胞肿瘤染色体中有25例(65.7%)发生1p LOH,26例(68.4%)发生19q LOH,5例(13.2%)发生10q LOH。结论实时荧光定量PCR微卫星分析技术快速、准确性高,可以用于脑胶质瘤标本染色体LOH的检测。 Objective To set up the new lab examination method for 1p,19q and 10q loss of heterozygosity(LOH) in glioma.Methods Thirty-eight cases of oligodendroglioma were enrolled into the study.Real-time quantitative polymerase chain reaction-based microsatellite analysis was performed on tumor tissues in order to study the status of chromosomes 1p,19q and 10q.Results Among the 38 cases of oligodendroglioma,25 cases(65.7%) showed 1p LOH,26 cases(68.4%) showed 19q LOH,while 5 cases(13.2%) showed 10q LOH.Conclusion Real-time quantitative polymerase chain reaction-based microsatellite analysis is a rapid and specific for detecting LOH in glioma tissues.
出处 《中国康复理论与实践》 CSCD 2011年第2期141-144,共4页 Chinese Journal of Rehabilitation Theory and Practice
基金 北京市自然科学基金资助项目(7102028) 北京市卫生系统高层次卫生技术人员培养计划(2009-3-23)
关键词 少突胶质细胞瘤 杂合性缺失 聚合酶链反应 oligodendroglioma loss of heterozygosity polymerase chain reaction
  • 相关文献

参考文献14

  • 1李守巍,袁芳,江涛,王忠诚.变性高效液相色谱检测少突胶质细胞瘤1p杂合性缺失[J].中国康复理论与实践,2009,15(2):120-122. 被引量:2
  • 2张淑坤,卢德宏,朴月善,蔡彦宁,徐庆中.即时荧光定量PCR微卫星分析技术检测少突胶质细胞肿瘤染色体1p/19q杂合性缺失[J].中华病理学杂志,2006,35(12):731-734. 被引量:9
  • 3何杰,郑声琴,乔颖娟,姚青,郭庆明,魏晓莹,黄培林.少突胶质细胞肿瘤染色体1p、19q和10q杂合性缺失与临床预后的关系[J].临床与实验病理学杂志,2006,22(4):444-448. 被引量:10
  • 4Brian Thiessen,John A. Maguire,Kelly McNeil,David Huntsman,Montgomery A. Martin,Doug Horsman.Loss of Heterozygosity for Loci on Chromosome Arms 1p and 10q in Oligodendroglial Tumors: Relationship to Outcome and Chemosensitivity[J]. Journal of Neuro - Oncology . 2003 (3)
  • 5Nigro J M,Takahashi MA,Ginzinger GG,et al.Detectionof 1p and 19q loss in oligodendroglioma by quantitative mic-rosatellite analysis,a real2ti me quantitative polymerasechain reaction assay. American Journal of Pathology . 2001
  • 6Sanson M,Leuraud P,Aguirre-Cruz L, et al.Analysis of loss of chromosome 10q, DMBT1 homozygous deletions and PTEN mutations in oligdendrogliomas. Journal of Neurosurgery . 2002
  • 7T Homma,T Fukushima,S Vaccarella,Y Yonekawa,PL Patre,S Franceschi,H Ohgaki.Correlation among pathology, genotype, and patient outcomes in glioblastoma. Journal of Neuropathology and Experimental Neurology . 2006
  • 8RB Jenkins,H Blair,KV Ballman,C Giannini,RM Arusell,M Law,H Flynn,S Passe,S Felten,PD Brown,EG Shaw,JC Buckner.A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. Cancer Research . 2006
  • 9Ino Y,Silver JS,Blazejewski L,et al.Common regions of deletion of chromosome 22q12. 3~q13. 1 and 22q13. 2 in human astrocytomas appear related to malignancy grade. Journal of Neuropathology &Experimental Neurology . 1999
  • 10Reifenberger J,Reifenberger G,Liu L,J et al.Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. American Journal of Pathology . 1994

二级参考文献40

  • 1何杰,郑声琴,乔颖娟,姚青,郭庆明,魏晓莹,黄培林.少突胶质细胞肿瘤染色体1p、19q和10q杂合性缺失与临床预后的关系[J].临床与实验病理学杂志,2006,22(4):444-448. 被引量:10
  • 2Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004[J]. CA Cancer J Clin,2004,54:8-29.
  • 3Kleihues P, Cavenee WK. World Health Organization Classification of Tumours[M]. Lyon: IARC Press,2000.
  • 4Cairneross JG, Ueki K, Zlatescu MC, et al. Specific genetic predictors of chemotherapeutic response and survival in pa tients with anaplastic oligodendrogliomas[J]. J Natl Cancer Inst, 1998,90 : 1473-1479.
  • 5Smith JS, Perry A, Borell TJ, et al. Alterations of chromosome arms lp and 19q as predictors of survival in oligoden-drogliomas, astrocytomas, and mixed oligoastrocytomas [J].J Clin Oncol,2000,18:636-645.
  • 6Bauman GS, Ino Y, Ueki K, et al. Allelic loss of chromosome lp and radiotherapy plus chemotherapy in patients with oligodendrogliomas[J]. Int J Radiat Oncol Biol Phys, 2000,48 : 825-830.
  • 7McDonald JM, See SJ, Tremont IW, et al. The prognostic impact of histology and lp/19q status in anaplastic oligoden droglial tumors[J]. Cancer,2005,104:1468-1477.
  • 8Ino Y, Zlatescu MC, Sasaki H, et al. Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome lp loss [J]. J Neurosurg,2000,92:983-990.
  • 9van den Bent MJ, Looijenga LH, Langenberg K, et al. Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features[J].Cancer, 2003,97:1276-1284.
  • 10Homma T, Fukushima T, Vaccarella S, et al. Correlation among pathology, genotype, and patient outcomes in glio blastoma[J].J Neuropathol Exp Neurol,2006,65:846-854.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部